Last reviewed · How we verify
Vehicle Ophthalmic Solution QID to BID — Competitive Intelligence Brief
phase 3
Ophthalmology
Small molecule
Live · refreshed every 30 min
Target snapshot
Vehicle Ophthalmic Solution QID to BID (Vehicle Ophthalmic Solution QID to BID) — Aldeyra Therapeutics, Inc.. A vehicle ophthalmic solution formulation designed to be administered topically to the eye at varying frequencies (four times daily reduced to twice daily).
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Vehicle Ophthalmic Solution QID to BID TARGET | Vehicle Ophthalmic Solution QID to BID | Aldeyra Therapeutics, Inc. | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Vehicle Ophthalmic Solution QID to BID CI watch — RSS
- Vehicle Ophthalmic Solution QID to BID CI watch — Atom
- Vehicle Ophthalmic Solution QID to BID CI watch — JSON
- Vehicle Ophthalmic Solution QID to BID alone — RSS
Cite this brief
Drug Landscape (2026). Vehicle Ophthalmic Solution QID to BID — Competitive Intelligence Brief. https://druglandscape.com/ci/vehicle-ophthalmic-solution-qid-to-bid. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab